Article Text
Electronic pages
Letter
Patients with non-Jo-1 anti-RNA-synthetase autoantibodies have worse survival than Jo-1 positive patients
Statistics from Altmetric.com
Footnotes
-
Competing interests None.
-
Provenance and peer review Not commissioned; externally peer reviewed.